8^th World Congress on Bioavailability & Bioequivalence: Pharmaceutical R & D Summit June 26-27, 2017 San Diego, California, USA

Prof. Mirko Diksic is a Killam Scholar Montreal Neurological Institute McGill University. Currently he is the Professor in Department of Neurology and Neurosurgery McGill University Montreal. He completed his education BSc 1966; MSc 1968; PhD 1970 at University of Zagreb Zagreb Croatia. He was honoured with Killam MNI Scholar 2002 to 2008. Rudjer Boskovic Scholarship 1962 to 1966, Killam MNI Scholar 1982 to 1991. Listed in the American Men and Women in Science Vol 2 1992 to 1993 p711. Listed in Who is Who in World Marquis 14th Edition 1997 Listed in Who is Who in Science and Engineering Marquis 4th Edition 1998 to 1999. He is referee for the journals Proc Nation Acad Sci USA; Journal of Cerebral Blood Flow and Metabolism; Journal of Nuclear Medicine; Journal of Neurochemistry; American J Physiology; J of American Psychiatry; Biological Psychiatry; plus eight others Research reviewer for Ten granting agencies and foundations. Member of the of The Brain Disorders and Clinical Neurosciences study sections BDCN5 of the NINDS 1999 to 2006. He had published 240 papers in refereed Journals, published 28 Abstracts and given 149 Invited lectures.

Evaluation of the brain serotonergic system in humans using positron emission tomography and in animals using autoradiography.

Dr. Mewa Singh heads research and product development Meda Biotech llc. With over 24 years of experience in the field of biopharmaceuticals. He provides expertise in Biotechnology, product development and the pharmaceuticals business market. Over the time period of 24 years. He has successfully launched products for diagnostics, vaccines, nutraceuticals and nanomedicines. He has applied five patents and is founder of two biotech startups ( Meda Biotech llc and Nano Biotech (P) Ltd. He has performed at administrative and senior management positions which included Director of R&D, Chief Scientific Officer, and COO positions. He holds M.S. in Biochemistry, M Phil in Biochemistry , Microbiology and Immunology, and PhD in Microbiology and Immunology.. Developing over 160 Nanomedicines for Pharmaceuticals, Nutraceuticals and Agrochemicals, he has been working with the strength of conviction that a new concept of Hybrid drugs, is the solubility solution for insoluble drugs. His discovery of Hybrid-Nanoengineeringâ„¢could have real significant therapeutic value for patients. This belief gave birth to a process of continual discovery and innovation, allowing him to develop many innovative medicines. Since 2002, his company Meda Biotech has been working to commercialize a technology that could make the treatment of cancer, pain and inflammation, more effective and less harmful to patients.

Product development in the field of ADC and Nanomedicnes.

Sinisa Franjic graduated from the Faculty of Law. Before academic career, he works as a journalist - freelance contributor 20 years. Until today, he write three books and 26 scientific papers. The successful defense of the doctoral dissertation on the topic from criminal law called "The Criminal justice and forensic aspects of computer criminality", he received a PhD degree.

Medical law, Health law, Computer criminality, Criminal law, Copyright law, Energy law.

Dr. Ahed J Alkhatib is currently working as clinical researcher at Jordan University of Science and Technology. He worked as Manager at CONEM (Council for nutritional and Environmental Medicine).He is the Chairman of Jordanian branch of CONEM. He was Editor-in-Chief at International Journal of Pharmaceutical Sciences and Drug Designing. He had over 120 Publications. He has scientific activity in Publishing of five medical hypotheses at medical news today. He is working to establish a new science, Molecular sociology. He was a Reviewer in several journals. He is working in studying therapeutic options of herbs on molecular level. He Works in research teams from different nationalities and places. He is interested in developing new model to understand the therapeutic response of HCV based on other non -conventional approaches.

Environmental Sociology, Environment, set up strong scientific hypothesis, Quantitative Tissue Analysis, Immunohistochemical Staining, Cancer Biomarkers, Immunohistochemistry, Special Stains, Biomarker Analysis, Cell Culture, Western Blot, Cancer Biology, Science Communication, Brain Tumors, Adult Neurogenesis, Ancient Philosophy, Anti Diabetic Drugs